SARS-CoV-2 spike protein antibody titers 6 months after SARS-CoV-2 mRNA vaccination among patients undergoing hemodialysis in Japan
Daisuke Kanai, Hiromichi Wakui, Tatsuya Haze, Kengo Azushima, Sho Kinguchi, Shunichiro Tsukamoto, Tomohiko Kanaoka, Shingo Urate, Yoshiyuki Toya, Nobuhito Hirawa, Hideaki Kato, Fumimasa Watanabe, Kanako Hanaoka, Masaaki Hanaoka, Hiroshi Mitsuhashi, Satoshi Yamaguchi, Toshimasa Ohnishi, Kouichi Tamura
Topics & Concepts
MedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)VirologySpike Protein2019-20 coronavirus outbreakVaccinationTiterAntibodyNephrologyCoronavirusImmunologyInternal medicineOutbreakInfectious disease (medical specialty)DiseaseSARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approachesCOVID-19 Clinical Research Studies